Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_assertion description "[GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_assertion evidence source_evidence_literature NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_assertion SIO_000772 18556336 NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_assertion wasDerivedFrom befree-20150227 NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_assertion wasGeneratedBy ECO_0000203 NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP861605.RAWYCAvBTO6oSttIs4wx5HPZsy024TANAmTwZ-Cn-_ngU130_provenance.